Ehsanian Reza, Fernandez Shawn, Cooper Amanda, Cushman Daniel M, Conger Aaron, Burnham Taylor, Fogarty Alexandra E, Aiyer Rohit, Smolinski Katie, McCormick Zachary L
Division of Pain Medicine, Department of Anesthesiology and Critical Care Medicine, University of New Mexico School of Medicine, Albuquerque, NM, USA.
University of New Mexico School of Medicine, Albuquerque, NM, USA.
Interv Pain Med. 2024 Aug 19;3(3):100432. doi: 10.1016/j.inpm.2024.100432. eCollection 2024 Sep.
Chronic knee pain often results from degenerative conditions such as knee osteoarthritis (OA) and can worsen after surgical interventions like total knee arthroplasty (TKA). Knee OA affects approximately 86 million individuals globally, leading to decreased function, mobility limitations, and disability. While TKA is a common surgical treatment for refractory knee OA, though up to 20 % of patients experience chronic post-operative knee pain worse than their pre-operative pain. Genicular nerve radiofrequency ablation (GnRFA) has emerged as a promising intervention for knee OA pain unresponsive to conservative management and for chronic post-TKA pain. GnRFA is an evidence-based technique supported by multiple prospective cohort studies and randomized controlled trials (RCTs). However, practice patterns and GnRFA techniques vary, and no peer-reviewed publication has yet quantified these variations in real-world clinical practice.
This study aims to understand the practice patterns of interventional pain physicians regarding patient selection, use of prognostic blocks, imaging, nerve targets, GnRFA types, and GnRFA techniques in treating knee pain secondary to OA or persistent post-TKA pain.
An anonymous 29-question survey was distributed via electronic mail to members of the International Pain and Spine Intervention Society (IPSIS) from January 16, 2024, to February 29, 2024. The survey assessed practice patterns related to patient selection, prognostic block use, and GnRFA techniques. Data were collected and stored using REDCap software, with descriptive statistics calculated.
A total of 150 completed surveys were analyzed, representing a completion rate of 2.0 % of surveys sent, 3.5 % of emails opened, and 56.8 % of those who clicked on the survey link. Respondents generally use common selection protocols regarding OA grade (Kelgren-Lawrence 3 and 4), duration of failed conservative care (3-6 months), a single anesthetic block paradigm, and use of fluoroscopic guidance for the GnRFA procedure. More variability was reported between respondents regarding the volume of anesthetic used during prognostic blocks, the threshold to consider a prognostic block "positive," the technology used, and nerves targeted during the GnRFA procedure.
The study provides valuable insights into the current practice patterns of GnRFA among interventional pain physicians. While there is consensus on some aspects of patient selection and procedural techniques, significant variability exists in prognostic block protocols and nerve targets for GnRFA. These findings highlight the need for further research to explore the long-term efficacy and safety of GnRFA and to standardize techniques and protocols across different practice settings, ultimately improving patient outcomes and quality of life. The low response rate may limit generalizability, and the survey did not include data on active tip sizes used for ablation or whether other procedures should be exhausted before resorting to GnRFA. Additionally, a survey to IPSIS membership only may not fully represent a diverse cohort of pain management specialists, potentially introducing sampling bias. Future studies should include members from a broader range of professional organizations to enhance representativeness.
慢性膝关节疼痛通常由诸如膝关节骨关节炎(OA)等退行性疾病引起,并且在诸如全膝关节置换术(TKA)等手术干预后可能会恶化。膝关节OA在全球约影响8600万人,导致功能下降、活动受限和残疾。虽然TKA是难治性膝关节OA的常见外科治疗方法,但高达20%的患者术后会出现比术前更严重的慢性膝关节疼痛。膝状神经射频消融术(GnRFA)已成为一种有前景的干预方法,用于治疗对保守治疗无反应的膝关节OA疼痛以及TKA后的慢性疼痛。GnRFA是一种基于证据的技术,得到了多项前瞻性队列研究和随机对照试验(RCT)的支持。然而,实践模式和GnRFA技术各不相同,且尚无同行评审的出版物对实际临床实践中的这些差异进行量化。
本研究旨在了解介入疼痛科医生在治疗OA继发的膝关节疼痛或TKA后持续性疼痛时,在患者选择、预后性阻滞的使用、影像学检查、神经靶点、GnRFA类型和GnRFA技术方面的实践模式。
2024年1月16日至2024年2月29日,通过电子邮件向国际疼痛与脊柱介入协会(IPSIS)成员发放了一份包含29个问题的匿名调查问卷。该调查评估了与患者选择、预后性阻滞使用和GnRFA技术相关的实践模式。使用REDCap软件收集和存储数据,并计算描述性统计数据。
共分析了150份完整的调查问卷,回复率为发送问卷的2.0%、打开邮件的3.5%以及点击调查链接者的56.8%。受访者通常采用关于OA分级(凯尔格伦 - 劳伦斯3级和4级)、保守治疗失败持续时间(3 - 6个月)、单一麻醉阻滞模式以及在GnRFA手术中使用透视引导的常见选择方案。在预后性阻滞期间使用的麻醉剂体积、将预后性阻滞视为“阳性”的阈值、使用的技术以及GnRFA手术期间靶向的神经方面,受访者之间报告的差异更大。
该研究为介入疼痛科医生目前的GnRFA实践模式提供了有价值的见解。虽然在患者选择和手术技术的某些方面存在共识,但在GnRFA的预后性阻滞方案和神经靶点方面存在显著差异。这些发现凸显了进一步研究的必要性,以探索GnRFA的长期疗效和安全性,并在不同实践环境中规范技术和方案,最终改善患者结局和生活质量。低回复率可能会限制普遍性,并且该调查未包括用于消融的活性尖端尺寸数据或在采用GnRFA之前是否应穷尽其他手术的数据。此外,仅对IPSIS成员进行调查可能无法充分代表不同的疼痛管理专家群体,可能会引入抽样偏差。未来的研究应纳入更广泛专业组织的成员以提高代表性。